Variable | pre-treatment | 12 months after treatment | P |
---|---|---|---|
Increased CSF WBC count | 2/6(33%) | 1/6(17%) | 0.505 |
Increased CSF protein concentration | 6/6(100%) | 1/6(17%) | 0.003 |
Four-fold decline in CSF RPR | – | – | – |
Four-fold decline in serum RPR | – | 3/6(50%) | – |
Median MMSE (IQR) | 14.5(11–18.25) | 17(13–19.25) | 0.048 |